Literature DB >> 7669686

Etoposide (VP-16) inhibits Epstein-Barr virus determined nuclear antigen (EBNA) synthesis.

H Kikuta, Y Sakiyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7669686     DOI： 10.1111/j.1365-2141.1995.tb05232.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  Shinsaku Imashuku; Tomoko Teramura; Kikuko Kuriyama; Junichi Kitazawa; Etsuro Ito; Akira Morimoto; Shigeyoshi Hibi
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

Review 2.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  Gritta E Janka
Journal:  Eur J Pediatr       Date:  2006-12-07       Impact factor: 3.860

3.  Epstein-Barr Virus Infection-associated Hemophagocytic Lymphohistiocytosis.

Authors:  Pamela Contreras-Chavez; Andrea Anampa-Guzmán; Safwan Gaznabi; Frederick Lansigan
Journal:  Cureus       Date:  2020-04-06

Review 4.  Hemophagocytic lymphohistiocytosis: an update for nephrologists.

Authors:  Edward J Filippone; John L Farber
Journal:  Int Urol Nephrol       Date:  2016-04-20       Impact factor: 2.266
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.